Valuation Due Diligence
Our valuation professionals bring investment banking and private equity experiences to the table to enable our clients to obtain an objective, independent valuation of the investment or divestiture target within the MedTech and Biotech sectors.
We utilize a combination of valuation methods to arrive at a realistic value of the investment or divestiture target to either help establish the value or provide an objective, independent second opinion.
Our valuation professionals build custom valuation models for each investment or divestiture target that account for key variables and risk factors like revenue potential, market conditions, operational factors, technology risks, financial & investing risk including multi-scenario sensitivity analyses.